Raymond Anderson - Net Worth and Insider Trading
Raymond Anderson Net Worth
The estimated net worth of Raymond Anderson is at least $60,255 dollars as of 2024-11-11. Raymond Anderson is the Director of Raptor Pharmaceutical Corp and owns about 6,695 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $60,255. Details can be seen in Raymond Anderson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Raymond Anderson has not made any transactions after 2015-09-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Raymond Anderson
Raymond Anderson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Raymond Anderson owns 2 companies in total, including Monopar Therapeutics Inc (MNPR) , and Raptor Pharmaceutical Corp (RPTP) .
Click here to see the complete history of Raymond Anderson’s form 4 insider trades.
Insider Ownership Summary of Raymond Anderson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2022-12-31 | director |
| RPTP | Raptor Pharmaceutical Corp | 2016-10-24 | director |
Raymond Anderson Latest Holdings Summary
Raymond Anderson currently owns a total of 1 stock. Raymond Anderson owns 6,695 shares of Raptor Pharmaceutical Corp (RPTP) as of September 2, 2015, with a value of $60,255.
Latest Holdings of Raymond Anderson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPTP | Raptor Pharmaceutical Corp | 2015-09-02 | 6,695 | 9.00 | 60,255 |
Holding Weightings of Raymond Anderson
Raymond Anderson Form 4 Trading Tracker
According to the SEC Form 4 filings, Raymond Anderson has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 4,916 shares on September 2, 2015, which brought Raymond Anderson around $61,499.
Insider Trading History of Raymond Anderson
- 1
Raymond Anderson Trading Performance
Raymond Anderson Ownership Network
Ownership Network List of Raymond Anderson
Ownership Network Relation of Raymond Anderson
Raymond Anderson Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Raymond Anderson is the director of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Operating Officer Andrew Cittadine , Chief Financial Officer Kim R Tsuchimoto , and director & Chief Executive Officer Chandler Robinson .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Raymond Anderson made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 128,508 shares made by Andrew Cittadine , and a net purchase of 1,550 shares made by Karthik Radhakrishnan .
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 1,550 shares, with a net purchase of 1,550 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net purchase of 27,252 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Raymond Anderson Mailing Address
Above is the net worth, insider trading, and ownership report for Raymond Anderson. You might contact Raymond Anderson via mailing address: C/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
